-
-
-
-
-
-
-
Phathom Pharmaceuticals Announces Pricing of $130 Million Public Offering of Common Stock and Pre-Funded Warrants
-
-
-
-
-
-
-
Guggenheim Reiterates Buy Rating on Phathom Pharmaceuticals (PHAT)
-
-
-
-
-
-
-
Phathom Pharmaceuticals to Participate in Upcoming Investor Healthcare Conferences
-
-
-
-
-
-
-
Phathom Pharmaceuticals Inc. (PHAT) Prices 2.25M Share Common Offering at $42/Sh
-
-
-
-
-
23,320 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

